CRDL
Cardiol Therapeutics·NASDAQ
--
--(--)
--
--(--)
CRDL fundamentals
Cardiol Therapeutics (CRDL) released its earnings on Nov 13, 2025: revenue was 0 (YoY --), met estimates; EPS was -0.0862 (YoY +35.19%), missed estimates.
Revenue / YoY
0
--
EPS / YoY
-0.0862
+35.19%
Report date
Nov 13, 2025
EPS
Actual | -0.1292 | -0.1813 | -0.087 | -0.1119 | -0.0776 | -0.0939 | -0.0885 | -0.0813 | -0.0905 | -0.0662 | -0.0905 | -0.1033 | -0.0731 | -0.133 | -0.0695 | -0.0695 | -0.0735 | -0.0862 |
Forecast | -0.1131 | -0.1103 | -0.1107 | -0.1359 | -0.1009 | -0.1048 | -0.059 | -0.0813 | -0.0943 | -0.0883 | -0.0905 | -0.0883 | -0.1033 | -0.0942 | -0.0881 | -0.0799 | -0.0808 | -0.0715 |
Surprise | -14.24% | -64.37% | +21.41% | +17.66% | +23.09% | +10.40% | -50.00% | 0.00% | +4.03% | +25.03% | 0.00% | -16.99% | +29.24% | -41.19% | +21.11% | +13.02% | +9.03% | -20.56% |
Revenue
Actual | 63.60K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Forecast | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings Call
You can ask Aime
What were the key takeaways from Cardiol Therapeutics’s earnings call?What factors drove the changes in Cardiol Therapeutics's revenue and profit?What is Cardiol Therapeutics's latest dividend and current dividend yield?Did Cardiol Therapeutics beat or miss consensus estimates last quarter?What were the key takeaways from Cardiol Therapeutics's earnings call?What is the revenue and EPS growth rate for Cardiol Therapeutics year over year?What is Cardiol Therapeutics's gross profit margin?What is the market's earnings forecast for Cardiol Therapeutics next quarter?
